Histone Deacetylase Inhibitor Alleviates the Neurodegenerative Phenotypes and Histone Dysregulation in Presenilins-Deficient Mice
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Histone acetylation has been shown to play a crucial role in memory formation, and histone deacetylase (HDAC) inhibitor sodium butyrate (NaB) has been demonstrated to improve memory performance and rescue the neurodegeneration of several Alzheimer's Disease (AD) mouse models. The forebrain presenilin-1 and presenilin-2 conditional double knockout (cDKO) mice showed memory impairment, forebrain degeneration, tau hyperphosphorylation and inflammation that closely mimics AD-like phenotypes. In this article, we have investigated the effects of systemic administration of NaB on neurodegenerative phenotypes in cDKO mice. We found that chronic NaB treatment significantly restored contextual memory but did not alter cued memory in cDKO mice while such an effect was not permanent after treatment withdrawal. We further revealed that NaB treatment did not rescue reduced synaptic numbers and cortical shrinkage in cDKO mice, but significantly increased the neurogenesis in subgranular zone of dentate gyrus (DG). We also observed that tau hyperphosphorylation and inflammation related protein glial fibrillary acidic protein (GFAP) level were decreased in cDKO mice by NaB. Furthermore, GO and pathway analysis for the RNA-Seq data demonstrated that NaB treatment induced enrichment of transcripts associated with inflammation/immune processes and cytokine-cytokine receptor interactions. RT-PCR confirmed that NaB treatment inhibited the expression of inflammation related genes such as S100a9 and Ccl4 found upregulated in the brain of cDKO mice. Surprisingly, the level of brain histone acetylation in cDKO mice was dramatically increased and was decreased by the administration of NaB, which may reflect dysregulation of histone acetylation underlying memory impairment in cDKO mice. These results shed some lights on the possible molecular mechanisms of HDAC inhibitor in alleviating the neurodegenerative phenotypes of cDKO mice and provide a promising target for treating AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Candidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577 · cited 1×
“Mutants in Presenilin 1 (PS1) or Presenilin 2 (PS2) genes have been identified as the major cause of familial AD (FAD; Levy-Lahad et al., 1995; Sherrington et al., 1995; Hardy, 1997).”
BackgroundDeficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F. (1998) · Nature · doi:10.1038/34910 · Cited by 1,818 · cited 1×
“The malfunction of Presenilins ultimately causes amyloid to accumulate into plaques in the brain (De Strooper et al., 1998).”
BackgroundSuppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor
Shimazu, T., Hirschey, M. D., Newman, J., He, W., Shirakawa, K., Le Moan, N., Grueter, C. A., Lim, H., Saunders, L. R., Stevens, R. D., et al. (2013) · Science · doi:10.1126/science.1227166 · Cited by 1,777
Amyloid, the presenilins and Alzheimer’s disease
Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370 · cited 1×
“Mutants in Presenilin 1 (PS1) or Presenilin 2 (PS2) genes have been identified as the major cause of familial AD (FAD; Levy-Lahad et al., 1995; Sherrington et al., 1995; Hardy, 1997).”
BackgroundThe growing landscape of lysine acetylation links metabolism and cell signalling
Choudhary, C., Weinert, B. T., Nishida, Y., Verdin, E., & Mann, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3841 · Cited by 1,324 · cited 1×
“In addition, a recent study has shown that calorie restriction can increase the level of an endogenous HDAC inhibitor β-Hydroxybutyrate, which has similar structure and effects on histone H3 acetylation as NaB (Shimazu et al., 2013; Choudhary et al., 2014).”
BackgroundRecovery of learning and memory is associated with chromatin remodelling
Fischer, A., Sananbenesi, F., Wang, X., Dobbin, M., & Tsai, L.-H. (2007) · Nature · doi:10.1038/nature05772 · Cited by 1,227 · cited 8×
“…enrichment could mimic the effect of HDAC inhibitor, probably by increasing histone 3 and 4 acetylation, restored the impaired learning and long-term memories in a neurodegenerative mice, which had already developed the significant brain atrophy and neuronal loss (Fischer et al., 2007).”
BackgroundInfluentialRegulation of histone acetylation during memory formation in the hippocampus
Levenson, J. M., O'Riordan, K. J., Brown, K. D., Trinh, M. A., Molfese, D. L., & Sweatt, J. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402229200 · Cited by 1,131 · cited 3×
“Much evidence indicates that administration of HDAC inhibitors was capable of not only facilitating memory formation in normal mice (Levenson et al., 2004), but also reversing the histone acetylation abnormality and improving memory in aged mice (Peleg et al., 2010) and neurodegenerative mice…”
BackgroundAltered Histone Acetylation Is Associated with Age-Dependent Memory Impairment in Mice
Peleg, S., Sananbenesi, F., Zovoilis, A., Burkhardt, S., Bahari-Javan, S., Agis-Balboa, R. C., Cota, P., Wittnam, J. L., Gogol-Doering, A., Opitz, L., et al. (2010) · Science · doi:10.1126/science.1186088 · Cited by 951 · cited 3×
“…of HDAC inhibitors was capable of not only facilitating memory formation in normal mice (Levenson et al., 2004), but also reversing the histone acetylation abnormality and improving memory in aged mice (Peleg et al., 2010) and neurodegenerative mice (Mastroeni et al., 2011; Lu et al., 2015).”
BackgroundAcetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy
Min, S.-W., Cho, S.-H., Zhou, Y., Schroeder, S., Haroutunian, V., Seeley, W. W., Huang, E. J., Shen, Y., Masliah, E., Mukherjee, C., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.044 · Cited by 949
An epigenetic blockade of cognitive functions in the neurodegenerating brain
Gräff, J., Rei, D., Guan, J.-S., Wang, W.-Y., Seo, J., Hennig, K. M., Nieland, T. J. F., Fass, D. M., Kao, P. F., Kahn, M., et al. (2012) · Nature · doi:10.1038/nature10849 · Cited by 853
Saura, C. A., Choi, S.-Y., Beglopoulos, V., Malkani, S., Zhang, D., Rao, B. S. S., Chattarji, S., Kelleher, R. J., Kandel, E. R., Duff, K., et al. (2004) · Neuron · doi:10.1016/s0896-6273(04)00182-5 · Cited by 757 · cited 10×
“05), which is consistent with the tau hyperphosphorylation observed by previous studies (Saura et al., 2004).”
BackgroundResultInfluentialRampon, C., Tang, Y.-P., Goodhouse, J., Shimizu, E., Kyin, M., & Tsien, J. Z. (2000) · Nature Neuroscience · doi:10.1038/72945 · Cited by 755
Self-citationKilgore, M., Miller, C. A., Fass, D. M., Hennig, K. M., Haggarty, S. J., Sweatt, J. D., & Rumbaugh, G. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.197 · Cited by 727 · cited 3×
“, in APP/PS1 mice (H3 and H4; Francis et al., 2009; Kilgore et al., 2010) and 3xTg-AD mice (H3; Cadena-del-Castillo et al.”
BackgroundConserved epigenomic signals in mice and humans reveal immune basis of Alzheimer's disease
Gjoneska, E., Pfenning, A. R., Mathys, H., Quon, G., Kundaje, A., Tsai, L.-H., & Kellis, M. (2015) · Nature · doi:10.1038/nature14252 · Cited by 576 · cited 1×
“Changes of histone H3 lysine 27 (H3K27) acetylation were also found at regulatory regions of not only synapse plasticity and learning related genes, but also immune and inflammatory response genes in the AD mouse model (Gjoneska et al., 2015).”
BackgroundRicobaraza, A., Cuadrado-Tejedor, M., Pérez-Mediavilla, A., Frechilla, D., Del Río, J., & García-Osta, A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.229 · Cited by 423
Govindarajan, N., Agis-Balboa, R. C., Walter, J., Sananbenesi, F., & Fischer, A. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110080 · Cited by 405 · cited 1×
“Accumulating evidences have shown that HDAC inhibitors have potential therapeutic roles and can restorememory function in several AD mouse models with amyloid deposition (Francis et al., 2009; Ricobaraza et al., 2009; Kilgore et al., 2010; Govindarajan et al., 2011; Sung et al., 2013).”
BackgroundHistone deacetylase 6 interacts with the microtubule‐associated protein tau
Ding, H., Dolan, P. J., & Johnson, G. V. W. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05564.x · Cited by 387
Ricobaraza, A., Cuadrado‐Tejedor, M., Marco, S., Pérez‐Otaño, I., & García‐Osta, A. (2012) · Hippocampus · doi:10.1002/hipo.20883 · Cited by 239 · cited 4×
“…Francis et al., 2009; Gräff et al., 2012; Rumbaugh et al., 2015), improving dendrite sprouting and dendritic spine densities (Fischer et al., 2007; Ricobaraza et al., 2012; Song et al., 2016), increasing number of synapses and activating the transcription of synaptic plasticity markers (Fischer…”
BackgroundInfluentialImmune hyperreactivity of Aβ plaque-associated microglia in Alzheimer's disease
Yin, Z., Raj, D., Saiepour, N., Van Dam, D., Brouwer, N., Holtman, I. R., Eggen, B. J. L., Möller, T., Tamm, J. A., Abdourahman, A., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.03.021 · Cited by 238 · cited 1×
“This was accompanied by a modulation in the inflammation and immune response pathway in the brain of cDKO mice (Yin et al., 2017).”
BackgroundInflammatory S100A9 and S100A12 proteins in Alzheimer's disease
Shepherd, C. E., Goyette, J., Utter, V., Rahimi, F., Yang, Z., Geczy, C. L., & Halliday, G. M. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.033 · Cited by 161
Sung, Y. M., Lee, T., Yoon, H., DiBattista, A. M., Song, J. M., Sohn, Y., Moffat, E. I., Turner, R. S., Jung, M., Kim, J., et al. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2012.10.005 · Cited by 152
Rumbaugh, G., Daws, S. E., Ozkan, E. D., Rojas, C. S., Hubbs, C. R., Aceti, M., Kilgore, M., Kudugunti, S., Puthanveettil, S. V., Sweatt, J. D., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.93 · Cited by 89 · cited 2×
“HDAC inhibitors exerted a potential effect in attenuating memory deficits (Fischer et al., 2007; Francis et al., 2009; Gräff et al., 2012; Rumbaugh et al., 2015), improving dendrite sprouting and dendritic spine densities (Fischer et al., 2007; Ricobaraza et al., 2012; Song et al., 2016),…”
BackgroundCadena-del-Castillo, C., Valdes-Quezada, C., Carmona-Aldana, F., Arias, C., Bermúdez-Rattoni, F., & Recillas-Targa, F. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-132285 · Cited by 35 · cited 1×
“In several AD mouse models, histone acetylation level was not altered, e.g., in APP/PS1 mice (H3 and H4; Francis et al., 2009; Kilgore et al., 2010) and 3xTg-AD mice (H3; Cadena-del-Castillo et al., 2014).”
BackgroundSong, J. M., Sung, Y. M., Nam, J. H., Yoon, H., Chung, A., Moffat, E., Jung, M., Pak, D. T. S., Kim, J., & Hoe, H.-S. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150717 · Cited by 19 · cited 1×
“…et al., 2012; Rumbaugh et al., 2015), improving dendrite sprouting and dendritic spine densities (Fischer et al., 2007; Ricobaraza et al., 2012; Song et al., 2016), increasing number of synapses and activating the transcription of synaptic plasticity markers (Fischer et al., 2007; Ricobaraza…”
Background
Cited by
The ageing epigenome and its rejuvenation
Zhang, W., Qu, J., Liu, G.-H., & Belmonte, J. C. I. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0204-5 · Cited by 458
Role of histone deacetylases and their inhibitors in neurological diseases
Zhang, L.-Y., Zhang, S.-Y., Wen, R., Zhang, T.-N., & Yang, N. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107410 · Cited by 84
Short-chain fatty acids: Important components of the gut-brain axis against AD
Huang, Y., Wang, Y. F., Miao, J., Zheng, R. F., & Li, J. Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116601 · Cited by 70
Cognitive epigenetic priming: leveraging histone acetylation for memory amelioration
Burns, A. M., & Gräff, J. (2021) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.08.011 · Cited by 62
“For example, histone acetylation, chromatin opening, and transcription are increased in the hippocampus within an hour after contextual learning or following electroconvulsive seizures [4,36 ,42], and these epigenetic changes are further enhanced by HDACi treatments [16,24].”
InfluentialEarly changes of fecal short‐chain fatty acid levels in patients with mild cognitive impairments
Gao, C., Li, B., He, Y., Huang, P., Du, J., He, G., Zhang, P., Tang, H., & Chen, S. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14252 · Cited by 50
Metadata
- Authors
- Cao, T., Zhou, X., Zheng, X., Cui, Y., Tsien, J. Z., Li, C., & Wang, H.
- Venue
- Frontiers in Aging Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2018-05-15
- Volume
- 10
- Pages
- 137-137
- ISSN
- 1663-4365 (ISSN-L)
- OpenAlex
- W2801978222
- Cited by
- 59
- References
- 24
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.